Bioavailability is the measure of how much of a substance actually reaches your bloodstream and cells
Deliberately pushing that pathway harder has a theoretical cancer-risk question attached that has never been studied in humans, because dihexa has never been studied in humans at all
Furthermore, it may take longer for the system to become active as shown in previous experiments before a district signal-to-noise ratio appears
However, if less severe self-reported hypoglycaemia is included, the prevalence is more variable: between 0.1% after GBP and 0.02% after vertical sleeve gastrectomy (VSG)1, to 30%4 and up to 75% if continuous glucose monitoring (CGM) is used5
Am J Physiol Gastrointest Liver Physiol 282(3):G424GG31 Delgado-Aros S, Vella A, Camilleri M, Low PA, Burton DD, Thomforde GM et al (2003) Effects of glucagon-like peptide-1 and feeding on gastric volumes in diabetes mellitus with cardio-vagal dysfunction